Lauren Biscaldi, MS, Managing Editor

Results of the SOUL clinical trial will be presented at a scientific meeting in 2025.

Opioid use disorder risk was higher in a cohort of patients with chronic pain without disability.

Multimodal analgesia provides more effective pain management—and leads to a decrease in opioid use.

Vaccination against HPV can prevent thousands of cases of cancer each year.

Research is limited on the effectiveness and efficacy of this class of medications.

Patients with chronic migraine can frequently overuse acute medications, leading to medication overuse headaches.

Three RSV vaccines are currently FDA approved for use in adults aged 60 or older.

Cases of meningococcal disease currently exceed prepandemic levels.

Gepotidacin is a first-in-class oral antibiotic with a novel mechanism of action.

Pharmacists can screen for social determinants of health and patient beliefs about medications as a way to improve adherence and subsequent outcomes in heart failure.

The first-line B/F/TAF regiment was evaluated in Hispanic/Latino patients, as well as in those with chronic kidney disease.

Research from ESMO 2024 focused on the relationship between survival outcomes and medication adherence.

GSK’s respiratory syncytial virus vaccine continued to provide adults aged 60 years and older with clinically meaningful protection.

Investigators compared semaglutide and other glucagon-like peptide-1 receptor agonists with dipeptidyl peptidase-4 inhibitors.

The once-daily, extended release, oral suspension medication was approved by the FDA in May 2024.

Vaccination against respiratory viruses such as RSV and the flu are crucial to prevent adverse outcomes in patients with heart failure.

Left ventricular ejection fraction, brain natriuretic peptide, and heart failure-related hospitalizations were among the improved metrics.

Research was presented at the Heart Failure Society of America 2024 Annual Meeting.

Without financial incentives, some senators expressed concerns that pharmaceutical research and development would stall.

Investigators used electronic health record data to compare outcomes of semaglutide vs other antidiabetic medications.

Senators sought to uncover why prices of Novo Nordisk’s GLP-1 receptor agonist semaglutide are significantly higher in the US compared with countries in Europe.

In the US, Ozempic costs more than 9 times what it does in Germany, while Wegovy is more than 4.5 times more expensive than in Denmark.

Eroxon topical gel addresses a significant unmet need for men experiencing erectile dysfunction.

The vaccine will be made available via third-party online pharmacies.

This approval offers an additional treatment option for a disease that can commonly return.

The “cuddle hormone” plays a powerful role in human behavior and may be an additional option to treat pain and manage opioid addiction.

Data from the SELECT clinical trial were analyzed to evaluate the role of semaglutide therapy on all-cause, cardiovascular, and non-cardiovascular mortality during the COVID-19 pandemic.